Ulcers and gastritis

Endoscopy

Volumn 42, Issue 1, 2010, Pages 38-41

  Dore, M P ^a,b   Graham, D Y ^b  

^a UNIVERSITY OF SASSARI   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; PEPSINOGEN;

BACTERIAL VIRULENCE; BACTERIUM DETECTION; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CHRONIC GASTRITIS; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HIGH RISK POPULATION; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; LIFESTYLE MODIFICATION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SHORT SURVEY; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH MUCOSA;

EID: 73949114198     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0029-1215314     Document Type: Short Survey

References (21)

1. Yamaji Y, Watabe H, Yoshida H, et al. High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors. Helicobacter 2009 14 81-86
2. Comfort M W. Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance. Ann Intern Med 1951 36 1331-1348
3. Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis 2007 8 8-14
4. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005 54 764-768
5. Ladeiras-Lopes R, Pereira A K., Noqueira A, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008 19 689-701
6. Graham D Y. Gastric cancer surveillance or prevention plus targeted surveillance. Jpn J Helicobacter Res 2009 10 9-14
7. Yang H B., Sheu B S., Wang S T., et al. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole. Am J Gastroenterol 2009 104 1642-1649
8. Kuipers E J., Lundell L, Klinkenberg-Knol E C., et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996 334 1018-1022
9. Kuipers E J., Klinkenberg-Knol E C., Vandenbroucke-Grauls C M., et al. Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl 1997 223 28-34
10. Graham D Y., Genta R M. Long-term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep 2008 10 543-547
11. Lundell L, Havu N, Miettinen P, et al. Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol Ther 2006 23 639-647
12. Kakinoki R, Kushima R, Matsubara A, et al. Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases. Dig Dis Sci 2009 54 614-620
13. Mesquita P, Raquel A, Nuno L, et al. Metaplasia a transdifferentiation process that facilitates cancer development: the model of gastric intestinal metaplasia. Crit Rev Oncog 2006 12 3-26
14. Tatematsu M, Tsukamoto T, Inada K. Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 2003 94 135-141
15. Graham D Y., Shiotani A. The time to eradicate gastric cancer is now. Gut 2005 54 735-738
16. Meining A, Morgner A, Miehlke S, et al. Atrophy-metaplasia-dysplasia- carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001 15 983-998
17. Ito T, Kobayashi D, Uchida K, et al. Helicobacter pylori invades the gastric mucosa and translocates to the gastric lymph nodes. Lab Invest 2008 88 664-681
18. Petersen A M., Krogfelt K A. Helicobacter pylori: an invading microorganism? A review. FEMS Immunol Med Microbiol 2003 36 117-126
19. Dubois A, Boren T. Helicobacter pylori is invasive and it may be a facultative intracellular organism. Cell Microbiol 2007 9 1108-1116
20. Semino-Mora C, Doi S Q., Marty A, et al. Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis 2003 187 1165-1177
21. Necchi V, Candusso M E., Tava F, et al. Intracellular, intercellular, and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by Helicobacter pylori. Gastroenterology 2007 132 1009-1023